Assessing the effects of estrogen on the dynamics of breast cancer

Computational and Mathematical Methods in Medicine

Volumn 2012, Issue , 2012, Pages

  Mufudza, Chipo ^a   Sorofa, Walter ^a   Chiyaka, Edward T ^a  

^a NATIONAL UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Zimbabwe)

Author keywords

[No Author keywords available]

Indexed keywords

DYNAMICS;

BREAST CANCER; GENERAL DYNAMICS; HOST CELLS; IMMUNE CELLS; IMMUNE RESPONSE; POPULATION MODEL; RISK FACTORS; TUMOR CELLS;

DISEASES;

ANTINEOPLASTIC AGENT; DNA; ESTROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ARTICLE; BODY MASS; BREAST BIOPSY; BREAST CANCER; BREAST CARCINOGENESIS; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; HORMONE SUBSTITUTION; HOST CELL; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; MASTECTOMY; MATHEMATICAL MODEL; MENOPAUSE; NATURAL KILLER CELL; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; IMMUNOLOGY; INCIDENCE; METABOLISM; RISK FACTOR; STATISTICAL MODEL; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CELL LINE, TUMOR; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INCIDENCE; MODELS, STATISTICAL; RISK FACTORS;

MLCS; MLOWN;

EID: 84872126788     PISSN: 1748670X     EISSN: 17486718     Source Type: Journal    
DOI: 10.1155/2012/473572     Document Type: Article

References (46)

1. American Cancer Society, Cancer Facts and Figures 2011
2. International Agency for Research on Cancer, Cancer Survival in Africa, Asia, the Caribbean and Central America 2011. Edited by R. Sankaranarayanan, R. Swaminathan, K. Jayant, and H. Brenner
3. American Cancer Society, Cancer Facts and Figures 2012
4. Tokunaga M., Land C. E., Tokuoka S., Nishimori I., Soda M., Akiba S., Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiation Research 1994 138 2 209 223 2-s2.0-0028358319 10.2307/3578591 (Pubitemid 24151448)
5. Miller A. B., Howe G. R., Sherman G. J., Lindsay J. P., Yaffe M. J., Dinner P. J., Risch H. A., Preston D. L., Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. The New England Journal of Medicine 1989 321 19 1285 1289 2-s2.0-0024448232 (Pubitemid 19267214)
6. Lanfranchi A., Brind J., Breast Cancer: Risks and Prevention 2007 4th Breast Cancer Prevention Institute
7. Thompson D., Easton D., The Breast cancer linkage consortium, Cancer incidencein BCR1-mutation carriers. Journal of the National Cancer Institute 2002 94 18 1358 1365 10.1093/jnci/94.18.1358
8. Avis N., Crawford S., Manuel J., Quality of life among younger women with breast cancer. Journal of Clinical Oncology 2005 23 15 3322 3330 2-s2.0-20644445443 10.1200/JCO.2005.05.130
9. National Cancer Institute, Breast Cancer Risk Increased in BRCA2 Carriers in Iceland. NCI Cancer Bulletin 2006 3 4
10. Yager J. D., Davidson N. E., Estrogen carcinogenesis in breast cancer. The New England Journal of Medicine 2006 354 3 270 282 2-s2.0-30944469849 10.1056/NEJMra050776 (Pubitemid 43113032)
11. Villasana M., A delay differential equation model for tumor growth [Ph.D. dissertation] 2001 Claremont University
12. Villasana M., Radunskaya A., A delay differential equation model for tumor growth. Journal of Mathematical Biology 2003 47 3 270 294 2-s2.0-1442290947 10.1007/s00285-003-0211-0 (Pubitemid 38272158)
13. De Pillis L. G., Radunskaya A., A mathematical tumor model with immune resistance and drug therapy. An optimal control approach. Journal of Theoretical Medicine 2001 3 2 79 100 2-s2.0-0035738977 (Pubitemid 34498513)
14. Bani G., Biggazi M., Sacchi T., Relaxin as a mammotrophic hormone. Experimental and Clinical Endocrinology 1991 10 143 150
15. Mercado-Simmen R. C., Bryant-Greenwood G. D., Green-wood F. C., Relaxin receptor in the rat myometrium: regulation by estrogen and relaxin. Endocrinology 1982 110 1 220 226 2-s2.0-0020040953 (Pubitemid 12198199)
16. Colditz G. A., Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. Journal of the National Cancer Institute 1998 90 11 814 823 2-s2.0-0032478958 (Pubitemid 28280547)
17. Kahlenborn C., Modugno F., Potter D. M., Severs W. B., Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis. Mayo Clinic Proceedings 2006 81 10 1290 1302 2-s2.0-33749247786 10.4065/81.10.1290 (Pubitemid 44484967)
18. Crooke P. S., Justenhoven C., Brauch H., Dawling S., Roodi N., Higginbotham K. S. P., Plummer W. D., Schuyler P. A., Sanders M. E., Page D. L., Smith J. R., Dupont W. D., Parl F. F., Estrogen metabolism and exposure in a genotypic-phenotypic model for breast cancer risk prediction. Cancer Epidemiology Biomarkers and Prevention 2011 20 7 1502 1515 2-s2.0-79960093250 10.1158/1055-9965.EPI-11-0060
19. Collaborative Group on Hormonal Factors in Breast Cancer, Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. The Lancet 1997 350 9084 1047 1059
20. Sacchi T., Relaxin influences the growth of MCF-7 breast cancer cells. Cancer 1992 70 3 639 643
21. Yaghoubi S., Barlow J., Kass P. H., Breast cancer and metals: a literature review, zero breast cancer [Ph.D. thesis] 2007 Davis, Calif, USA University of Califonia
22. Yafia R., Dynamics analysis and limit cycle in a delayed model for tumor growth with quiescence. Nonlinear Analysis: Modelling and Control 2006 11 1 95 110
23. Green L. E., Dinh T. A., Smith R. A., An estrogen model: the relationship between body mass index, menopausal status, estrogen replacement therapy, and breast cancer risk. Computational and Mathematical Methods in Medicine 2012 2012 8 792375 10.1155/2012/792375
24. DePillis L. G., Radunskaya A., A mathematical model of immune response to tumor invasion, Computational fluid and solid mechanics. Proceedings of the 2nd MIT Conference on Computational Fluid and Solid Mechanics June 2003 1661 1668
25. Newbury G., A numerical study of a delay differential equation model for breast cancer [M.S. thesis] 2007 Faculty of the Virginia Polytechnic Institute and State University
26. Mattsson H. A., Nyquist K. U., A mathematical investigation of breast cancer and tumor growth. Statistical analysis and stochastic modelling2009 [M.S. thesis] 2009 Gothenburg, Sweden Department of Mathematical Statistics, Chalmers University of Technology, University of Gothenburg
27. Kuznetsov V. A., Makalkin I. A., Taylor M. A., Perelson A. S., Nonlinear dynamics of immunogenic tumors. Parameter estimation and global bifurcation analysis. Bulletin of Mathematical Biology 1994 56 2 295 321 2-s2.0-0028388757
28. Burton A. C., Rate of growth of solid tumours as a problem of diffusion. Growth, Development and Aging 1966 30 2 157 176 2-s2.0-0013916715
29. Adam J. A., A simplified mathematical model of tumor growth. Mathematical Biosciences 1986 81 2 229 244 2-s2.0-0022799748 (Pubitemid 17172482)
30. Casciari J. J., Sotirchos S. V., Sutherland R. M., Mathematical modelling of microenvironment and growth in EMT6/Ro multicellular tumour spheroids. Cell Proliferation 1992 25 1 1 22 2-s2.0-0026575319
31. Gail M. H., Brinton L. A., Byar D. P., Corle D. K., Green S. B., Schairer C., Mulvihill J. J., Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. Journal of the National Cancer Institute 1989 81 24 1879 1886 2-s2.0-0024801278 (Pubitemid 20026073)
32. Boice J. D., Miller R. W., Childhood and adult cancer after intrauterine exposure to ionizing radiation. Teratology 1999 59 4 227 233 (Pubitemid 29231839)
33. Donovan M., Tiwary C. M., Axelrod D., Sasco A. J., Jones L., Hajek R., Sauber E., Kuo J., Davis D. L., Personal care products that contain estrogens or xeno-estrogens may increase breast cancer risk. Medical Hypotheses 2007 68 4 756 766 2-s2.0-33846502282 10.1016/j.mehy.2006.09.039 (Pubitemid 46157081)
34. Zeigler B., Kim T., Praehofer H., Theory of Modelling and Simulation. Integrating Discrete Event and Continuous Complex Dynamic System 2000 Academic press
35. Goldstein R., Wainer G., Modelling tumor-immune systems with Cell-DEVS. Proceedings of the European Conference on Modelling and Simulation (ECMS '08) June 2008 Nicosia, Cyprus
36. Chia Y. L., Salzman P., Plevritis S. K., Glynn P. W., Simulation-based parameter estimation for complex models: a breast cancer natural history modelling illustration. Statistical Methods in Medical Research 2004 13 6 507 524 2-s2.0-9444244514 10.1191/0962280204sm380ra (Pubitemid 39562705)
37. Steel G. G., Growth Kinetics of Tumours 1977 Clarendon Press
38. Sachs R. K., Hlatky L. R., Hahnfeldt P., Simple ODE models of tumor growth and anti-angiogenic or radiation treatment. Mathematical and Computer Modelling 2001 33 12-13 1297 1305 2-s2.0-0035953488 10.1016/S0895-7177(00)00316- 2 (Pubitemid 32417939)
39. Gatenby R. A., The potential role of transformation-induced metabolic changes in tumor-host interaction. Cancer Research 1995 55 18 4151 4156 2-s2.0-0029081536
40. Neves A. A., Brindle K. M., Assessing responses to cancer therapy using molecular imaging. Biochimica et Biophysica Acta 2006 1766 2 242 261 2-s2.0-33847267302 10.1016/j.bbcan.2006.10.002
41. Jimenez R. P., Hernandez E. O., Tumor host dynamics under radiotherapy. Chaos, Solitons & Fractals 2011 44 9 685 692 10.1016/j.chaos.2011.06.001
42. 0 and its role on global stability. Mathematical Approaches for Emerging and Reemerging Infectious Diseases: An Introduction 2002 125 229 250 IMA
43. Curran E. M., Judy B. M., Duru N. A., Wang H. Q., Vergara L. A., Lubahn D. B., Estes D. M., Estrogenic regulation of host immunity against an estrogen receptor-negative human breast cancer. Clinical Cancer Research 2006 12 19 5641 5647 2-s2.0-33750361956 10.1158/1078-0432.CCR-05-1117 (Pubitemid 44629590)
44. 2 cell cycle arrest. Cancer Research 2004 64 1 423 428 2-s2.0-1642535535 10.1158/0008-5472.CAN-03- 2446 (Pubitemid 38114127)
45. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., Tujague M., Ström A., Treuter E., Warner M., Gustafsson J. Å., Estrogen receptors: how do they signal and what are their targets. Physiological Reviews 2007 87 3 905 931 2-s2.0-34447523339 10.1152/physrev.00026.2006 (Pubitemid 47084672)
46. Roggia C., Gao Y., Cenci S., Weitzmann M. N., Toraldo G., Isaia G., Pacifici R., Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proceedings of the National Academy of Sciences of the United States of America 2001 98 24 13960 13965 2-s2.0-0035923727 10.1073/pnas.251534698 (Pubitemid 33116006)